acc01701 |
Bcl-2-associated transcription factor 1 |
phosphorylation |
Ser658 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01702 |
Bcl-2-associated transcription factor 1 |
phosphorylation |
Ser496 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01703 |
Cyclin-dependent kinase 12 |
phosphorylation |
Ser681 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01704 |
Splicing factor C9orf78 |
phosphorylation |
Ser15 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01705 |
Splicing factor C9orf78 |
phosphorylation |
Ser261 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01706 |
CCR4-NOT transcription complex subunit 2 |
phosphorylation |
Ser165 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01707 |
NHS-like protein 3 |
phosphorylation |
Ser929 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01708 |
Cleavage and polyadenylation specificity factor subunit 2 |
phosphorylation |
Ser419 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01709 |
Cleavage and polyadenylation specificity factor subunit 2 |
phosphorylation |
Ser420 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01710 |
Cleavage and polyadenylation specificity factor subunit 2 |
phosphorylation |
Ser423 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01711 |
Arginine-glutamic acid dipeptide repeats protein |
phosphorylation |
Ser679 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01712 |
Tuftelin-interacting protein 11 |
phosphorylation |
Ser98 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01713 |
Tight junction protein ZO-2 |
phosphorylation |
Ser130 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01714 |
Leucine-rich repeat and WD repeat-containing protein 1 |
phosphorylation |
Ser243 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01715 |
LIM domain and actin-binding protein 1 |
phosphorylation |
Ser490 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01716 |
LIM domain and actin-binding protein 1 |
phosphorylation |
Ser362 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01717 |
AF4/FMR2 family member 4 |
phosphorylation |
Ser703 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01718 |
Anaphase-promoting complex subunit 2 |
phosphorylation |
Ser470 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01719 |
Jupiter microtubule associated homolog 1 |
phosphorylation |
Ser87 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01720 |
REST corepressor 1 |
phosphorylation |
Ser260 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01721 |
RNA-binding protein Raly |
phosphorylation |
Ser135 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01722 |
F-box only protein 4 |
phosphorylation |
Ser12 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01723 |
RNA-binding protein NOB1 |
phosphorylation |
Ser201 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01724 |
Ras GTPase-activating protein-binding protein 2 |
phosphorylation |
Ser141 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01725 |
Protein kinase C and casein kinase substrate in neurons protein 2 |
phosphorylation |
Ser399 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01726 |
LIM and calponin homology domains-containing protein 1 |
phosphorylation |
Ser233 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01727 |
LIM and calponin homology domains-containing protein 1 |
phosphorylation |
Ser217 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01728 |
LIM and calponin homology domains-containing protein 1 |
phosphorylation |
Ser718 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01729 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser1403 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01730 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser1404 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01731 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser377 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01732 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser424 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01733 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser353 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01734 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser1499 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01735 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser1383 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01736 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser1384 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01737 |
Thyroid hormone receptor-associated protein 3 |
phosphorylation |
Ser243 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01738 |
Thyroid hormone receptor-associated protein 3 |
phosphorylation |
Ser248 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01739 |
Thyroid hormone receptor-associated protein 3 |
phosphorylation |
Ser253 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01740 |
Thyroid hormone receptor-associated protein 3 |
phosphorylation |
Ser682 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01741 |
WW domain-binding protein 11 |
phosphorylation |
Ser353 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01742 |
WW domain-binding protein 11 |
phosphorylation |
Ser361 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01743 |
Charged multivesicular body protein 3 |
phosphorylation |
Ser200 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01744 |
Nucleolar complex protein 2 homolog |
phosphorylation |
Ser672 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01745 |
Nucleolar complex protein 2 homolog |
phosphorylation |
Ser673 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01746 |
Centrosomal protein of 170 kDa protein B |
phosphorylation |
Ser853 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01747 |
Transmembrane protein 184B |
phosphorylation |
Ser402 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01748 |
Transmembrane protein 184B |
phosphorylation |
Ser403 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01749 |
Protein PRRC2C |
phosphorylation |
Ser2105 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01750 |
PAX3- and PAX7-binding protein 1 |
phosphorylation |
Ser557 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|